ArticleJAMA oncology2019

Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program.

Noah Z Feit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.